Pfizer Inc

NYSE: PFE
$29.22
-$0.05 (-0.2%)
Closing Price on October 18, 2024

PFE Articles

These stocks should do well for years regardless of who the next president is. They all have incredible franchises, long and mature product silos and, importantly, very strong consumer brand...
One time when missing earnings estimates doesn't matter much is when there is bidding war for the company. That's the position that Medivation found itself in.
A pharmaceutical company could face a threat to one of its products for a number of reasons, ranging from an improved formulation to a patent expiry and the opening of the floodgates for generic...
May 3, 2016: Markets opened lower Tuesday following some overnight weakness in overseas markets resulting from weak data on trade from both China and Europe and a strengthening dollar. Energy prices...
Pfizer reported better-than-expected first-quarter 2016 results before markets opened Tuesday morning.
Pfizer is scheduled to report its first-quarter financial results before the markets open on Tuesday.
24/7 Wall St. has put together a preview of Pfizer, Chesapeake Energy and some of the other major companies reporting their quarterly results this week.
The April 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest was mixed.
Freeport-McMoRan saw a bump in the number of its shares short, while Sprint’s short interest was essentially the same as at the end of March.
Attaining a certain drug can mean the difference between life and death for millions of Americans. These essential products also help generate billions for drug manufacturers. Pharmaceutical...
Apple continues to be the American company with most money parked offshore. The amount has reached $181 billion.
These four Jefferies Franchise Picks are rated Buy and pay the highest dividends. They make good sense for investors now.
Oxfam reports that 50 U.S. companies have $1.3 trillion offshore. It is hard to figure out why it matters to Oxfam, but the data are true nonetheless.
Each week the analysts at Jefferies come out with their top value stock ideas and this week's selections are not only solid ideas, but also pay outstanding dividends.
The March 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest was mixed.